(IMMU) Alert: Shareholder Class Action Against Immunomedics Survives Motion to Dismiss; Should Management be Held Accountable for Investors Losses? Contact Johnson Fistel

SAN DIEGO, Aug. 20, 2020 /PRNewswire/ -- Johnson Fistel, LLP is investigating potential claims on behalf of Immunomedics Inc. (NASDAQ: IMMU) ("Immunomedics" or the "Company") against certain of its officers and directors. Specifically, a class-action lawsuit pending in the United States...

from PR Newswire: https://ift.tt/2Ym4oOW